Hansa Biopharma AB (publ) (STO:HNSA)
Sweden
· Delayed Price · Currency is SEK 27.08
+1.06 (4.07%)
Apr 28, 2026, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.76 billion as of April 28, 2026. Its market cap has increased by 85.56% in one year.
Market Cap
2.76B
Enterprise Value
3.22B
Revenue
190.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.08
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.76B, an increase of 8,872.78%. That is a compound annual growth rate of 28.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 2.84B |
| Egetis Therapeutics AB | 2.31B |
| Flerie AB | 2.27B |
| Saniona AB | 1.94B |
| BioInvent International AB | 1.45B |
| Genovis AB (publ.) | 1.32B |
| Xspray Pharma AB | 1.13B |
| Medivir AB | 1.05B |